ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 88 filers reported holding ONCOCYTE CORP in Q1 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $144,000 | -38.7% | 160,238 | +1.4% | 0.02% | -31.2% |
| Q1 2022 | $235,000 | -57.0% | 158,004 | -37.4% | 0.03% | -53.6% |
| Q4 2021 | $547,000 | +153.2% | 252,298 | +570.3% | 0.07% | +187.5% |
| Q2 2021 | $216,000 | -6.9% | 37,641 | -15.7% | 0.02% | -36.8% |
| Q1 2021 | $232,000 | -43.0% | 44,626 | -73.8% | 0.04% | -43.3% |
| Q4 2020 | $407,000 | +45.9% | 170,146 | -15.4% | 0.07% | +42.6% |
| Q3 2020 | $279,000 | – | 201,047 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 17,349,945 | $61,766,000 | 3.15% |
| Defender Capital, LLC. | 1,960,820 | $6,935,000 | 2.26% |
| Millrace Asset Group, Inc. | 613,885 | $2,185,000 | 1.36% |
| PURA VIDA INVESTMENTS, LLC | 12,223,953 | $43,517,000 | 1.32% |
| Penbrook Management LLC | 577,200 | $2,055,000 | 1.28% |
| ACT CAPITAL MANAGEMENT, LLC | 330,000 | $1,175,000 | 0.61% |
| AWM Investment Company, Inc. | 717,000 | $2,553,000 | 0.25% |
| Colonial River Wealth Management, LLC | 66,200 | $218,000 | 0.15% |
| CALIBER WEALTH MANAGEMENT, LLC | 66,200 | $218,000 | 0.15% |
| Fort Sheridan Advisors LLC | 110,000 | $392,000 | 0.13% |